NSEGeneral Updates3d ago · 2 Sept 2026, 06:30 pm
General Updates
Gufic Biosciences Limited · GUFICBIO
✦ AI SummaryMgmt Change
Gufic Biosciences Limited has informed the Exchange about the promotion and change in designation of two senior management personnel, Ms. Ami Shah as Head-Legal and Mr. Pinak Padhya as President – Sales & Marketing, effective September 02, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gufic Biosciences Limited has informed the Exchange about Promotion and Change in Designation of Senior Management Personnel
Attachments (1)
📄pdf
Download →
GUFIC_02092026182917_finalintimation.pdf
View document text
259/LG/SE/SEP/2026/GBSL
September 02, 2026
To To
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code : 509079 Scrip Symbol : GUFICBIO
Subject : Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Promotion and Change in Designation of Senior
Management Personnel
Dear Sir/Madam,
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we
wish to inform you that, based on the recommendation of Nomination & Remuneration Committee,
the Board of Directors, vide Circular Resolution passed today i.e. September 02, 2026 has approved
the promotion and consequent change in designation of the following Senior Management Personnel
of the Company, with effect from September 02, 2026:
1. Ms. Ami Shah promoted as Head-Legal, while continuing to hold the position of Company
Secretary & Compliance Officer, Key Managerial Personnel of the Company
2. Mr. Pinak Padhya - promoted as President – Sales & Marketing
The details required under Regulation 30 of the Listing Regulations read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith as
under:
Particulars Ms. Ami Shah Mr. Pinak Padhya
Reason for change viz. Promotion of Ms. Ami Shah Promotion of Mr. Pinak Padhya
appointment, re-appointment, from Company Secretary, from Vice President – Sales &
resignation, removal, death or Compliance Officer and Marketing to President – Sales &
otherwise Senior Manager – Legal to Marketing
Company Secretary,
Compliance Officer and
Head- Legal.
Date of appointment/re- With effect from September With effect from September 02,
appointment/cessation (as 02, 2026 2026
applicable) & term of
appointment/re-appointment
Brief profile (in case of Ms. Ami Shah is a qualified Mr. Pinak Padhya is a seasoned
appointment) Company Secretary and holds pharmaceutical sales and
a degree in Law (LL.B.). She marketing professional with
has been associated with the over 28 years of leadership
Company for over 10 years experience in the
and joined the Company as pharmaceutical industry. He is a
Company Secretary & Pharmacy Graduate with an
Compliance Officer and MBA in Marketing, combining
Executive – Legal. strong technical understanding
with extensive commercial and
She has extensive experience managerial experience.
in handling the corporate
secretarial affairs of the Over the course of his career, he
Company, including has worked with leading
corporate governance, pharmaceutical organisations
statutory and regulatory including Sun Pharma, Ranbaxy,
compliances and matters Glenmark, Elder, Medley and
under the Companies Act, Cadila Pharma, gaining broad-
2013, Listing Regulations and based experience in sales,
other applicable laws. She marketing, brand management
has also gained substantial and business development. He
experience in handling legal has handled portfolios across
matters, including drafting, multiple therapeutic areas,
reviewing and negotiating including Orthopaedics,
domestic and international Gastrointestinal, Gynaecology,
commercial agreements, Herbal, Dermatology, Pediatrics
litigation and court matters, and General Practice.
legal notices and providing
legal advisory on matters His core areas of expertise
relating to the Company’s include strategic brand building,
pharmaceutical business and cluster growth, product
operations. launches, market expansion and
management of multi-therapy
Her experience also includes portfolios. He has demonstrated
management of the an ability to understand market
Company’s intellectual opportunities, develop
property matters, including appropriate commercial
trademarks, as well as strategies, strengthen customer
advising various functions of relationships and lead teams
the Company on legal and towards achievement of
regulatory matters. She has business objectives.
played an active role in
strengthening the Company’s His extensive industry
legal, governance and experience, diverse therapeutic
compliance framework. exposure, strong sales and
marketing expertise and proven
track record of business growth
position him well to assume
Prior to joining the Company, enhanced leadership
she was associated with the responsibilities and contribute
JM Baxi Group as Senior to the Company’s continued
Executive – Secretarial Team. growth and expansion.
Disclosure of relationships Not Applicable Not Applicable
between directors (in case of
appointment of director)
Kindly take the same on your record.
Thanking You,
Yours truly,
For Gufic Biosciences Limited
Ami Shah
Company Secretary & Compliance Officer
Membership No. A39579